GLP-1s are an approved treatment for those with a BMI over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
Higuchi T, Abe M, Yamazaki T, Mizuno M, Okawa E, Ando H
We have been successfully using GLP-1s for years at our clinic in conjunction with our four-pillar metabolic health program - focusing on a healthy metabolism: food, sleep, emotional wellness and exercise
Dual-receptor peptide constructs, which permit examination of both GLP-1R and GIPR engagement within a single molecular framework, represent an active area of research
Traditionally, metformin has been the first-line therapy